Phaos Technology Holdings (Cayman) (POAS) Current Assets (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) posted Current Assets of $1.0 million for Q4 2025, down 10.07% on a QoQ basis from $1.1 million in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Current Assets (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman)'s Current Assets history runs 2 years deep, the most recent figure standing at $1.0 million for Q4 2025.

Quarterly Current Assets changed N/A year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $1.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.1 million, down 67.71% from the prior year.
Current Assets was $1.0 million for Q4 2025 at Phaos Technology Holdings (Cayman), down from $1.1 million in the prior quarter.
Across five years, Current Assets topped out at $3.5 million in Q2 2024 and bottomed at $1.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Assets (Qtr)
1	Abbott Laboratories	183.67 Bn	176.38 Bn	6.27 Bn	25.51 Bn
2	Stryker	128.91 Bn	126.03 Bn	3.81 Bn	13.34 Bn
3	Medtronic	108.84 Bn	99.62 Bn	6.41 Bn	24.79 Bn
4	Boston Scientific	68.57 Bn	67.12 Bn	3.61 Bn	8.68 Bn
5	Edwards Lifesciences	48.68 Bn	45.01 Bn	1.29 Bn	6.23 Bn
6	Dexcom	28.42 Bn	27.31 Bn	750.30 Mn	4.33 Bn
7	GE HealthCare Technologies	28.38 Bn	26.09 Bn	1.98 Bn	10.43 Bn
8	Smith & Nephew	26.94 Bn	26.36 Bn	-	4.10 Bn
9	Koninklijke Philips	25.50 Bn	22.38 Bn	2.07 Bn	11.45 Bn
10	Phaos Technology Holdings (Cayman)	6.24 Mn	6.18 Mn	-	1.02 Mn

Download Data